NIH Director States Unified Approach to Institute Operations
The NIH Director announced a unified approach to advance the agency’s mission to align Institute priorities and funding approaches.
Read moreMain Content
Milestone Reached: More Than 200 FDA-Cleared AI Medical Imaging Products Now Available
Nov. 8, 2022
The medical imaging field has hit a major milestone with more than 200 FDA cleared Artificial Intelligence (AI) products now available on the market. This is a significant increase from just 50 cleared AI medical imaging products just at the end of November 2019. This growth in the AI medical imaging space is a clear indication of the increase in investment and efforts being put into bringing AI technology to the healthcare industry.
The availability of more than 200 FDA cleared AI medical imaging products presents numerous opportunities for healthcare providers to leverage AI technology to improve patient care and outcomes.
If you're interested in learning more about the current state of AI medical imaging, be sure to check out the DSI's AI-Central resource at https://aicentral.acrdsi.org/.
The availability of more than 200 FDA cleared AI medical imaging products presents numerous opportunities for healthcare providers to leverage AI technology to improve patient care and outcomes.
If you're interested in learning more about the current state of AI medical imaging, be sure to check out the DSI's AI-Central resource at https://aicentral.acrdsi.org/.
Related ACR News
ACR Sets the Standard: Comment on Draft AI Practice Parameters
ACR invites comments on draft AI Practice Parameters, setting standards for safe, ethical, and effective AI use in radiology.
Read moreACR 2025 Dives Into College’s AI Efforts
Recent ACR Data Science Institute initiatives ARCH-AI, AI Central and Assess-AI were discussed at ACR 2025.
Read more